NeuroBo Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • NeuroBo Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 8.61M shares, a 77.6% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.61M -29.8M -77.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 8.22M -30M -78.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.91M -22.3M -81.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.91M +1.73M +54.3% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 38.4M +37.5M +4224% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 38.2M +11.6M +43.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 27.2M +515K +1.93% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.18M -22.3M -87.5% Dec 31, 2022 10-K 2024-03-28
Q3 2022 889K -21.4M -96% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 26.7M +4.49M +20.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 26.7M +4.49M +20.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 25.4M +5.76M +29.3% Dec 31, 2021 10-K 2023-03-30
Q3 2021 22.3M +5.86M +35.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 22.2M +5.74M +35% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 22.2M +6.49M +41.4% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 19.7M +4.08M +26.2% Dec 31, 2020 10-K 2022-03-31
Q3 2020 16.4M +1.55M +10.5% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 16.4M +2.16M +15.2% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 15.7M +1.41M +9.9% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 15.6M +10.4M +202% Dec 31, 2019 10-K 2021-04-15
Q3 2019 14.9M +607K +4.26% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 14.3M +33.1K +0.23% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 14.3M +33.1K +0.23% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 5.17M -5.47M -51.4% Dec 31, 2018 10-K 2020-03-30
Q3 2018 14.3M +3.63M +34.2% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 14.2M +3.62M +34.2% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 14.2M +3.64M +34.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 10.6M +1.36M +14.7% Dec 31, 2017 10-K 2019-03-18
Q3 2017 10.6M +1.36M +14.7% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 10.6M +6.85M +182% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 10.6M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 9.27M +5.51M +147% Dec 31, 2016 10-K 2018-03-20
Q3 2016 9.27M Sep 30, 2016 10-Q 2016-11-02
Q2 2016 3.76M Jun 30, 2016 10-Q 2016-09-14
Q4 2015 3.76M Dec 31, 2015 10-K 2017-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.